Related references
Note: Only part of the references are listed.Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma
Natsuko Tsuda Okita et al.
GASTRIC CANCER (2011)
Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses
Beom Su Kim et al.
AMERICAN JOURNAL OF SURGERY (2010)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification
Guenter Kloeppel et al.
NEUROENDOCRINOLOGY (2009)
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich-Frank Pape et al.
CANCER (2008)
Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: Report of a case
Naohiko Koide et al.
SURGERY TODAY (2007)
Gastric neuroendocrine carcinoma: Clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers
Yoon-Jung Boo et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors
Adriana V. Safatle-Ribeiro et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Gastric large cell neuroendocrine carcinomas: A distinct clinicopathologic entity
Shi-Xu Jiang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Share Paper
